The National Institute of Allergy and Infectious Diseases has awarded a 7-year, $9.8 million grant to develop an AIDS vaccine to four Seattle-based research organizations and Rockefeller University.
National Institutes of Health funding is the lifeblood of U.S. biomedical research centers, particularly for teams working on speculative, early-phase projects like AIDS vaccines. Dr. Dong-Pyou Han was part of one such team, but NIH has banned him from receiving grants for three years for falsifying research.
An HIV/AIDS vaccine candidate developed by researchers at Oregon Health & Science University shows promise for advancing treatment of the disease, a crippling worldwide public health problem.
Oregon Health & Science University (OHSU) researchers think the inability to find an effective AIDS vaccine may come down to not finding the right virus strain to make one.
In Nigeria, around 3.3 million people were living with HIV/AIDS in 2010. To try to combat this, the country is kick-starting its vaccine program again.
Scientists for the first time have successfully used a vaccine to protect monkeys from contracting their version of the AIDS virus. Johnson & Johnson ($J&J) subsidiary Crucell NV of the
The FDA has approved more than 30 medicines to treat HIV/AIDS since the disease became widespread in the early 1980s. The life expectancy for many patients with the disease has increased considerably
New technology developed by MIT researchers can measure how the body's T cells react to cells infected with HIV. They hope that the technology could make it easier to design and monitor vaccines
Norwegian biotech Bionor Pharma has released results from a study of its therapeutic HIV vaccine, Vacc-4x. After initially planning to shelve the vaccine last October, the company is now plotting
Researchers sponsored by the International AIDS Vaccine Initiative (IAVI) have isolated 17 novel antibodies against HIV, an achievement that could eventually lead to vaccines against the virus. The